ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: communication

Rheumatology Drug Updates: Labeling for Fluoroquinolones; FDA to Review Benzhydrocodone/Acetaminophen Combination

Michele B. Kaufman, PharmD, BCGP  |  July 12, 2016

FDA Restricts Fluoroquinolone Use The U.S. Food and Drug Administration (FDA) has twice previously communicated safety information about systemic fluoroquinolones—in August 2013 and July 2008. The safety issues of this medication class described in its latest Drug Safety Communication were also discussed at a November 2015 FDA Advisory Committee meeting.1 The FDA is now advising…

Filed under:AnalgesicsDrug Updates Tagged with:acetaminophenanalgesicantibioticsbenzhydrocodonedrugFDAfluoroquinolonespatient careRheumatic DiseaserheumatologySafetytherapyTreatment

Practicing Telemedicine Raises Legal Considerations for Rheumatologists

Steven M. Harris, Esq.  |  July 12, 2016

With the evolution and advancement of technology, it was only a matter of time before such changes affected the medical industry. Although the concept of telemedicine dates back more than 50 years, emphasis on cost-effective quality healthcare coupled with technological advancements has caused a resurgence of telemedicine in recent years. What constitutes telemedicine largely depends…

Filed under:Legal UpdatesPractice Support Tagged with:DiagnosisLegalpatient carephysicianrheumatologistrheumatologyTechnologytelehealthtelemedicineTreatment

From the Expert: Enhance Your Teachable Moments to Attract Residents to Rheumatology

Richard Quinn  |  July 8, 2016

Attracting medical residents to rheumatology has been difficult. However, Eli Miloslavsky, MD, believes enhancing the teaching skills of rheumatology fellows, enabling them to push through barriers on the ward and leverage teachable moments with residents, may improve patient care and influence a resident’s choice of subspecialty…

Filed under:Education & Training Tagged with:Clinical PracticeEducationfellowshipinternal medicineTraining

RA Choice: A Tool to Improve Patient Literacy

Arthritis Care & Research  |  July 5, 2016

Doctor-patient communication is critical for successfully treating rheumatoid arthritis. But a majority of RA patients report suboptimal shared decision making, sometimes due to language barriers, lack of time, limited health literacy and other factors. A recent pilot study sought to improve patient understanding and communication by employing an adapted medication guide and decision aid during clinical visits. Use of the tool, RA Choice, resulted in an increase in patient knowledge, and a majority of clinicians found it helpful…

Filed under:ConditionsResearch RheumRheumatoid Arthritis Tagged with:Arthritis Care & Researchlearning toolsMedicationpatient communicationpatient education

Doctors Blame Many Factors for Futile Care, Themselves Included

Randi Belisomo  |  June 20, 2016

(Reuters Health)—Doctors who were asked about causes of inappropriate care at the end of life didn’t have to look far to place blame. They blamed themselves. Australian researchers interviewed 96 physicians from 10 medical specialties and asked them to describe situations when patients received end of life care that the doctors felt was inappropriate. Futile…

Filed under:ConditionsPractice Support Tagged with:end-of-lifefutile medical treatmentmortalitypatient carephysician

University of Alabama at Birmingham’s Division of Clinical Immunology & Rheumatology Recognized for Excellence

Gretchen Henkel  |  June 13, 2016

An interdisciplinary and collaborative environment is a critical factor for the advancement of basic science and clinical research in the academic environment, says William J. Koopman, MD, former director of the University of Alabama at Birmingham’s (UAB’s) Division of Clinical Immunology and Rheumatology. And in 1977, when he was being recruited by Division Director J….

Filed under:ConditionsPediatric ConditionsProfessional TopicsProfilesResearch Rheum Tagged with:CareerexcellenceImmunologyPediatricProfileResearchrheumatologyUniversity of Alabama at Birmingham

Find Your Mentor in Medicine

Karen Appold  |  June 13, 2016

Medicine has traditionally been an apprenticeship model. The most elemental and constructive method of passing on knowledge is the mentor–mentee relational experience. Mentorship encompasses not only the role of teacher, but also that of coach, role model, advisor and confidante. Matthew J. Koster, MD, rheumatology fellow and instructor in medicine, Mayo Clinic, Rochester, Minn., can…

Filed under:Career DevelopmentProfessional Topics Tagged with:Career developmentMentorresidentrheumatology

How Rheumatologists Can Plan for Extended Work Absences

Karen Appold  |  June 13, 2016

Sometimes, life calls for you to be out of the office for a length of time. Whether the absence is planned or not, it’s important to consider the best actions to take given the circumstances to ensure patients are cared for during your absence. Alexa Meara, MD, clinical instructor and rheumatologist, The Ohio State University…

Filed under:Practice SupportWorkforce Tagged with:absenceemployeematernity leavepatient carephysicianPractice Managementrheumatologist

The ACR’s Collaboration with International Rheumatology Associations Promotes Progress

Joan M. Von Feldt, MD, MSEd, FACR, FACP, & Elizabeth A. Schlenk, PhD, RN  |  June 12, 2016

More than 10 years ago, New York Times journalist Thomas Friedman opined an old-world perspective that the world is, in fact, flat. In an article published on April 3, 2005, Mr. Friedman contended that “Individuals must, and can, now ask: Where do I fit into the global competition and opportunities of the day, and how…

Filed under:Education & TrainingEULAR/OtherMeeting ReportsPresident's Perspective Tagged with:AC&RAFLARAmerican College of Rheumatology (ACR)APLAR Asia PacificAssociation of Rheumatology Professionals (ARP)collaborationEducationEULARglobalILARInternationalPANLARprogressrheumatology

Patients with OA Respond to Low-Dose SoluMatrix Meloxicam; Off-Label Use of Ketoconazole Results in Death

Michele B. Kaufman, PharmD, BCGP  |  June 8, 2016

In a clinical trial, patients with osteoarthritis taking low-dose SoluMatrix meloxicam used less rescue medication to manage pain. Also, the FDA has issued a new warning against using oral ketoconazole off label to treat onychomycosis and fungal skin infections…

Filed under:AnalgesicsDrug Updates Tagged with:Drug SafetyFDAFood and Drug AdministrationketoconazolemeloxicamOsteoarthritisPainsafety warning

  • « Previous Page
  • 1
  • …
  • 60
  • 61
  • 62
  • 63
  • 64
  • …
  • 97
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences